Cargando…

Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation

Activation of G(s)-coupled receptors enhances engraftment of hematopoietic stem and progenitor cells (HSPCs). We tested the hypothesis that treprostinil, a prostacyclin analog approved for the treatment of pulmonary hypertension, can be repurposed to improve hematopoietic stem cell transplantation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazemi, Zahra, Bergmayr, Christian, Prchal-Murphy, Michaela, Javaheri, Tahereh, Themanns, Madeleine, Pham, Ha T. T., Strohmaier, Wolfgang, Sexl, Veronika, Freissmuth, Michael, Zebedin-Brandl, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885501/ https://www.ncbi.nlm.nih.gov/pubmed/26989084 http://dx.doi.org/10.1124/mol.116.103267

Ejemplares similares

Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation
por: Zebedin-Brandl, Eva, et al.
Publicado: (2019)

Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome
por: Themanns, Madeleine, et al.
Publicado: (2018)

Treprostinil stimulates the engraftment of haematopoetic stem cells
por: Hussain, Filza, et al.
Publicado: (2011)

Targeting PI3Kδ: One man’s meat is another man’s poison
por: Prchal-Murphy, Michaela, et al.
Publicado: (2013)

Pharmacological stimulation of murine and human hematopoetic stem cells
por: Bergmayr, Christian, et al.
Publicado: (2012)

STAT1 Ser727 – key regulator for NK cell-mediated cytotoxicity and tumor surveillance
por: Putz, Eva M, et al.
Publicado: (2008)

PI3Kδ Is Essential for Tumor Clearance Mediated by Cytotoxic T Lymphocytes
por: Putz, Eva Maria, et al.
Publicado: (2012)

PI3Kδ is indispensable for CTL-mediated cytotoxicity
por: Putz, Eva M, et al.
Publicado: (2011)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria
por: Kossmeier, Michael, et al.
Publicado: (2021)

Unexpected role of STAT1 serine727 for NK cell function
por: Putz, Eva M, et al.
Publicado: (2009)

Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
por: Putz, Eva Maria, et al.
Publicado: (2016)

Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021)

P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
por: Schirripa, A., et al.
Publicado: (2022)

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells
por: Mayer, Isabella Maria, et al.
Publicado: (2022)

P1407: CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE
por: Mayer, I., et al.
Publicado: (2022)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013)

STAT5B(N642H) is a driver mutation for T cell neoplasia
por: Pham, Ha Thi Thanh, et al.
Publicado: (2017)

Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension
por: Smadja, David M., et al.
Publicado: (2010)

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023)

Inhaled treprostinil: a therapeutic review
por: Channick, Richard N, et al.
Publicado: (2012)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

Successful management of an inadvertent excessive treprostinil overdose
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2013)

Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro
por: Schmetterer, Klaus G., et al.
Publicado: (2019)

In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
por: Prchal-Murphy, Michaela, et al.
Publicado: (2015)

STAT5B(N642H) drives transformation of NKT cells: a novel mouse model for CD56(+) T-LGL leukemia
por: Klein, Klara, et al.
Publicado: (2019)

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
por: Kolb, Martin, et al.
Publicado: (2022)

P1310: A ROBUST APPROACH FOR THE GENERATION OF FUNCTIONAL HEMATOPOIETIC PROGENITOR CELL LINES TO MODEL LEUKEMIC TRANSFORMATION
por: Doma, E., et al.
Publicado: (2022)

The folding interactome of GPCRs
por: Bergmayr, Christian, et al.
Publicado: (2011)

Dosing characteristics of oral treprostinil in real-world clinical practice
por: Balasubramanian, Vijay P., et al.
Publicado: (2018)

Oral treprostinil use in children: a multicenter, observational experience
por: Kanaan, Usama, et al.
Publicado: (2019)

An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail
por: Hill, Nicholas S., et al.
Publicado: (2020)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
por: Alissa, Ibrahim, et al.
Publicado: (2023)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
por: Gauani, Helena, et al.
Publicado: (2023)

A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration
por: Kumar, Parag, et al.
Publicado: (2016)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain
por: Light, Allison, et al.
Publicado: (2017)

Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension
por: Desole, Susanna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i9hpeopt96hrpg925bk5r2u225